Registration is now open for Ophthalmic Drugs Conference 2021

SMi Group reports: The agenda and speaker line-up for the upcoming Ophthalmic Drugs Conference which will convene on 22nd and 23rd November 2021 has been released.
By: SMi Group
LONDON - June 9, 2021 - PRLog -- SMi Group are proud to announce that the 4th annual Ophthalmic Drugs Virtual Conference will commence on the 22nd and 23rd November 2021. This event will explore unique challenges and latest breakthroughs in ocular drug development and delivery. The packed agenda will offer multiple presentations, through which insights into new industry developments and clinical trials, innovations in the treatment of rare diseases, regulatory perspectives and advances in gene therapy can be gained.

Interested parties can register and sign up to the event via . Register by 30th June 2021 and save £200.

Featured speakers will include:

Aniz Girach, Chief Medical Officer, ProQr Therapeutics
Victor Chong, Global Medical Head, Retinal Health, Boehringer Ingelheim
Daniel Chung, Chief Medical Officer, Sparingvision
Jaya Chidambaram, Associate Clinical Director, Roche Genentech
Kerrie Brady, Chief Executive Offcer at Ocuterra Therapeutics
Peter Morgan-Warren, Ophthalmology Specialist; Senior Medical Advisor, Bayer
Gregoire Schwach, Leader Ocular and Drug Delivery, PTD Biologics Europe, Roche
Francine Behar-Cohen, Chief Innovation Officer, Eyevensys
Grace C Chang, Chief Medical Officer, Oxurion nv
Magali Taiel, Chief Medical Officer, Gensight-Biologics
Alan Franklin, CEO, Forwardvue Pharma
Brian Levy, CEO, InflammX Therapeutics

Two interactive post conference workshops will also run on 24th November 2021. These will feature Dr. Thakur Raghu Raj Singh, Reading in Pharmaceutics, Queen's University Belfast and Laurence Fitzheny, Lecturer, Project Coordinator, ORBITAL-ITN leading the workshop on Novel Platforms in Ocular Drug Delivery. As well as, Brian Levy, CEO, InflammX Therapeutics running a workshop on Ophthalmic Drug Delivery Development - Trials and Tribulations.

This two-day agenda will offer peer-to-peer networking opportunities with leaders in the ophthalmic sphere, from Heads of Drug Development and Senior Directors of Ophthalmology, all the way to academic forerunners in the research into ocular therapy.

The event brochure with the agenda and speaker line-up is available from the website; those interested in attending can register at:

Ophthalmic Drugs
22nd – 23rd November 2021
London, UK

Interactive Workshops: 24th November 2021


For media queries please contact Jinna Sidhu at or call +44 (0)20 7827 6088


Jinna Sidhu
Email:*** Email Verified
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Most Viewed
Daily News

Like PRLog?
Click to Share